Resonance Health Ltd - RHT share price

About

Resonance Health Limited is an Australian MedTech company specializing in the development and provision of non-invasive medical imaging software and services. They focus on creating and commercializing software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Their product portfolio includes Core Lab and artificial intelligence (AI) powered products, designed to collaborate with clinicians and radiologists in diagnosing and managing patients across various clinical settings. Their core SaMD product, FerriScan, is a non-invasive liver analysis technology used for assessing iron levels in the liver. Additionally, they offer other SaMDs such as Cardiac T2, used for evaluating iron in the heart, and HepaFat-Scan for assessing fat in and around the liver. Resonance Health also provides several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart. These products aim to enhance medical diagnosis and patient management with the help of advanced imaging technologies and artificial intelligence algorithms.